VentriPoint Diagnostics Ltd

NEW
FRA:5V7 (Canada)  
€ 0.10 -0.0030 (-2.91%) Apr 1
At Loss
Market Cap:
€ 16.94M ($ 18.29M)
Enterprise V:
€ 17.79M ($ 19.21M)
Volume:
-
Avg Vol (2M):
15.23K
Trade In:
What is a stock summary page? Click here for an overview.

Business Description

Description
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.08
Equity-to-Asset -3.43
Debt-to-Equity -0.59
Debt-to-EBITDA -0.3
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -131.56
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -12.6
3-Year EPS without NRI Growth Rate -14.5
3-Year FCF Growth Rate -17

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.28
Quick Ratio 0.28
Cash Ratio 0.06
Days Sales Outstanding 37.3

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.3
Shareholder Yield % -1.45

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -3643.07
Net Margin % -3719.71
FCF Margin % -2692.39
ROA % -361.83
ROIC % -1258.45
3-Year ROIIC % -1131.94
ROC (Joel Greenblatt) % -2145.58

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -5.56
EV-to-EBITDA -5.63
EV-to-Revenue 200.71
EV-to-FCF -8.01
Earnings Yield (Greenblatt) % -17.99
FCF Yield % -13.98

Financials

FRA:5V7's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

VentriPoint Diagnostics Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.092
EPS (TTM) (€) -0.028
Beta 2.47
3-Year Sharpe Ratio 0.1
3-Year Sortino Ratio 0.21
Volatility % 74.3
14-Day RSI 54.02
14-Day ATR (€) 0.007789
20-Day SMA (€) 0.099725
12-1 Month Momentum % -45.36
52-Week Range (€) 0.0405 - 0.188
Shares Outstanding (Mil) 159.82

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

VentriPoint Diagnostics Ltd Filings

Filing Date Document Date Form
No Filing Data

VentriPoint Diagnostics Ltd Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

VentriPoint Diagnostics Ltd Frequently Asked Questions

What is VentriPoint Diagnostics Ltd(FRA:5V7)'s stock price today?
The current price of FRA:5V7 is €0.10. The 52 week high of FRA:5V7 is €0.19 and 52 week low is €0.04.
When is next earnings date of VentriPoint Diagnostics Ltd(FRA:5V7)?
The next earnings date of VentriPoint Diagnostics Ltd(FRA:5V7) is .
Does VentriPoint Diagnostics Ltd(FRA:5V7) pay dividends? If so, how much?
VentriPoint Diagnostics Ltd(FRA:5V7) does not pay dividend.

Press Release

Subject Date
No Press Release